内部人士可能会获得普通股东无法享受的可观财务利益。
拟议的交易可能包含限制更优竞争报价的条款。
鼓励股东与本公司联系，讨论他们的权利和选择，且无需支付任何费用或义务。我们将以风险代理的方式处理任何事务，您无需承担我们的法律费用或支出的自付费用。
, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否存在违反联邦证券法和/或对股东的信托责任的潜在行为，涉及：
Kezar Life Sciences, Inc. (NASDAQ: KZR) 以每股 6.955 美元现金和一项不可转让的或有价值权出售给 Aurinia Pharmaceuticals Inc. 如果您是 Kezar 的股东， 请点击这里了解您的法律权利和选择。
Equitable Holdings, Inc. (NYSE: EQH) 与 Corebridge Financial, Inc.的合并，其中每一股 Equitable 普通股将被交换为合并公司普通股的 1.55516 股。拟议交易完成后，Equitable 股东将拥有合并公司约 49% 的股份。如果您是 Equitable 的股东， 请点击这里了解您的法律权利和选择。
Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX) 以每股 5.50 美元出售给 Agero, Inc. 如果您是 Urgent.ly 的股东， 请点击这里了解您的权利和选择 。
代表股东，Halper Sadeh LLC 可能寻求增加对价、额外披露和信息，或其他救济和利益。
Halper Sadeh LLC 代表全球受证券欺诈和公司不当行为影响的投资者。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
律师广告。以往的结果并不保证类似的结果。
联系信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
世界贸易中心一号
85 层
纽约，NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
来源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0"/>

安盛公平

CRBG

Aurinia制药

AKRO

ULYX

Halper Sadeh LLC 正在调查 Kezar Life Sciences、Equitable Holdings 和 Urgent.ly 是否存在潜在的联邦证券法违规和违反信托责任的行为。该公司担心内部人士可能会在普通股东的利益受损的情况下获得财务利益。他们鼓励股东讨论他们在拟议交易中的权利和选择，这些交易包括 KZR 出售给 Aurinia Pharmaceuticals、EQH 与 Corebridge Financial 的合并，以及 ULYX 出售给 Agero。Halper Sadeh LLC 提供基于成功收费的法律援助

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
<div class="lb-trans">内部人士可能会获得普通股东无法享受的可观财务利益。
</div>The proposed transactions may contain terms that could limit superior competing offers.
<div class="lb-trans">拟议的交易可能包含限制更优竞争报价的条款。
</div>Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">鼓励股东与本公司联系，讨论他们的权利和选择，且无需支付任何费用或义务。我们将以风险代理的方式处理任何事务，您无需承担我们的法律费用或支出的自付费用。
</div>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投资者权益法律事务所，正在调查以下公司是否存在违反联邦证券法和/或对股东的信托责任的潜在行为，涉及：
</div>Kezar Life Sciences, Inc. (NASDAQ: KZR)'s sale to Aurinia Pharmaceuticals Inc. for $6.955 in cash per share and one non-transferable contingent value right. If you are a Kezar shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Kezar Life Sciences, Inc. (NASDAQ: KZR) 以每股 6.955 美元现金和一项不可转让的或有价值权出售给 Aurinia Pharmaceuticals Inc. 如果您是 Kezar 的股东， 请点击这里了解您的法律权利和选择。
</div>Equitable Holdings, Inc. (NYSE: EQH)'s merger with Corebridge Financial, Inc. whereby each outstanding share of Equitable common stock will be exchanged for 1.55516 shares of the combined company's common stock. Upon closing of the proposed transaction, Equitable shareholders will own approximately 49% of the combined company. If you are an Equitable shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Equitable Holdings, Inc. (NYSE: EQH) 与 Corebridge Financial, Inc.的合并，其中每一股 Equitable 普通股将被交换为合并公司普通股的 1.55516 股。拟议交易完成后，Equitable 股东将拥有合并公司约 49% 的股份。如果您是 Equitable 的股东， 请点击这里了解您的法律权利和选择。
</div>Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX)'s sale to Agero, Inc. for $5.50 per share. If you are an Urgent.ly shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Urgent.ly, Inc. (OTC MarketsOTCQB: ULYX) 以每股 5.50 美元出售给 Agero, Inc. 如果您是 Urgent.ly 的股东， 请点击这里了解您的权利和选择 。
</div>On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
<div class="lb-trans">代表股东，Halper Sadeh LLC 可能寻求增加对价、额外披露和信息，或其他救济和利益。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受证券欺诈和公司不当行为影响的投资者。我们的律师在实施公司改革和为受欺诈投资者追回数百万美元方面发挥了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律师广告。以往的结果并不保证类似的结果。
</div>Contact Information:
<div class="lb-trans">联系信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>One World Trade Center
<div class="lb-trans">世界贸易中心一号
</div>85th Floor
<div class="lb-trans">85 层
</div>New York, NY 10007
<div class="lb-trans">纽约，NY 10007
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">来源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDE0Jk5ld3NJdGVtSWQ9TlkzNDE2NCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MTQxNjEzUFJfTkVXU19VU1BSX19fX19OWTM0MTY0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY34164&amp;Transmission_Id=202604141613PR_NEWS_USPR_____NY34164&amp;DateId=20260414"/>

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

prnewswire

Urgently

Corebridge Financial

Akero Therapeutics

Kezar Life Sciences

Urgent.ly Inc.

KZR、安盛公平、Urgent.ly Inc.是否为其股东争取到公平的交易？